Ivermectin cream, 1% is indicated for the treatment of inflammatory lesions of rosacea.
The etiology of rosacea, with an emphasis on the role of UV radiation and exposome, and to review the importance of nonpharmacologic strategies focusing on photoprotection, is described.
Patients with ocular rosacea who underwent combined treatments reported less discomfort.
The efficacy and tolerability of daily cream containing N-butanoyl-l-glutathione (GSH-C4), beta-glycyrrhetinic, and azelaic acid for treatment in patients with mild to moderate rosacea was evaluated.
Vyne Therapeutics announced the availability of Zilxi (minocycline) topical foam 1.5% for the treatment of inflammatory lesions of rosacea in adults.
Epsolay is an investigational topical cream that utilizes the Company’s patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules.
Combination laser and intradermal botulinum toxin therapy for the management of rosacea is reported in this novel study.
Hypertension, dyslipidemia, and obesity were among the conditions investigators reviewed as being affected by the underlying inflammation associated with rosacea.
Skin redness and other symptoms associated with rosacea were found to improve with the use of a skincare regimen formulated for the treatment of centrofacial erythema.
Current smoking status is associated with a lower risk for rosacea, a study finds.